Anyone who works in supply chains knows that the industry is about far more than simply getting things from one place to another. There are a lot of details involved, and items can be held up easily if there are potential rule infractions.
As you might expect, drugs and medicines are among the things that can cause difficulties. As every country has its own laws on these things, the potential for issues in shipments is substantial. And this is just one of the challenges that creating and shipping drugs can involve.
Potential issues in the supply chain
In the sections below, we will take a closer look at issues that can arise at different points in the supply chain with drug-related items. As you will see, the complexities are many and varied, and this is what makes the job of pharmaceutical companies a challenge. Whether it be preventative drugs, drugs to treat rare illnesses, or even drugs for medical tests – as you can find with Exploro products – the process is very complicated and potentially fraught with roadblocks.
Production challenges
The potential issues that drug companies have to deal with start with production and manufacturing. Because of the highly specialized nature of many drugs, a variety of production challenges can arise:
- Lack of equipment. Pharmaceutical manufacturing can require specialized equipment that is costly and difficult to obtain. Some facilities are simply not up-to-date, and have difficulties meeting modern standards.
- Outside factors. Any number of outside factors can contribute to production issues. Geopolitical problems can cause barriers with shipment, natural disasters can prevent facilities from working properly, and other factors can play a role that can cause potential issues with production.
- Production limits. Smaller companies often face issues with production capacity and therefore have difficulties meeting deadlines for large orders.
- Quality control. Because of the sensitive nature of drug production, quality control standards can be very strict, some manufacturers have difficulties meeting these standards.
Challenges with API sourcing
Because many drugs require unique components, obtaining the necessary raw materials and active pharmaceutical ingredients (APIs) can be difficult. Specifically:
- Suppliers can be limited. When companies rely on particular suppliers, any problems with these suppliers can leave the companies stuck for unknown periods of time.
- Inability to meet API quality. If standards in API quality are not met, manufacturers might have to reject components, which can cause further delays.
Issues with components can arise regardless of whether a drug has been around for a long time, or new on the market. Even something like THC detox supplements can face issues if the necessary components are unavailable.
Potential regulatory problems
There can also be a variety of problems with meeting regulations. For one thing, regulatory reviews can take time, and any delays can set manufacturers back significantly.
Differences in understanding regarding whether or not regulations are met is another potential issue. Manufacturers and regulating bodies also need to agree on what constitutes shortage of drugs.
Changes in the market
Finally, the market itself can pose challenges to drug companies. For one thing, if certain drugs have low profit margins, they might be subject to production cuts. This can happen with the production of generic drugs, for example.
When profits are low, investment in manufacturing can slow down, and this can cause even further shortages. When these cycles begin, it can be difficult to change them.
Corruption in the system
It is also not a secret that the industry itself has faced numerous issues with corruption. This includes, but is not limited to:
- Corruption in clinical trials. Everything from the design to the reporting of clinical trials can be influenced by certain parties to favor a particular outcome. Even data can be manipulated to reflect individual interests.
- Regulation scandals. The pharmaceutical industry has strong lobbyists and can influence regulators by making outsized contributions. Lobbyists can also influence the prices that are set for certain drugs.
- Falsified medicine. Some drugs can even be falsified, especially in countries where most people cannot afford to pay for quality items.
- Marketing manipulation. Some pharmaceutical companies are known to manipulate the way that drugs are marketed. They can artificially inflate the degree of efficacy that certain drugs have, and even convince doctors and other health professionals to do the same.
A complex but necessary process
As you can see, the process of creating and getting drugs to market is complicated and includes many components that rely on outside factors. If even one factor that is necessary in the supply chain is off, the entire process can be thrown out of whack. Particularly for smaller companies, being prepared for potential challenges is necessary to stay afloat and meet consumer demand. This is what makes the world of drug manufacturing as important and valuable as it is.
